In summary, we confirm the profound defect of the Nrf2 antioxidant pathway in skin fibroblasts of SSc patients and mice, together with the aggravation of the disease in nrf2-KO SSc mice. The gene discussed is NFE2L2; the disease is systemic sclerosis.